1617-53-4 Usage
Description
Different sources of media describe the Description of 1617-53-4 differently. You can refer to the following data:
1. Amentoflavone , a bisapigenin , is one of the best inhibitors in the class of flavonoids , since its active dose is about 0.12uM.
Amentoflavone (C30H18O10) is a well-known biflavonoid occurring in many natural plants. This polyphenolic compound has been discovered to have some important bioactivities, including anti-inflammation, anti-oxidation, anti-diabetes, and anti-senescence effects on many important reactions in the cardiovascular and central nervous system, etc. Over 120 plants have been found to contain this bioactive component, such as Selaginellaceae, Cupressaceae, Euphorbiaceae, Podocarpaceae, and Calophyllaceae plant families.
Amentoflavone is a natural product with several associated biological effects.Its ability to block NF-xβ is the key for its anti-inflammatory potential. BETs were identified as NF-xβ promoters, with JQ-1 being highly effective in psoriasis models.
2. Amentoflavone is a biflavonoid originally isolated from Selaginella. It has a wide variety of biological effects including antibacterial, antioxidant, antiviral, antidiabetic, and neuroprotective activities. Amentoflavone has antiviral activity against the influenza A subtypes H1N1 and H3N2, influenza B, and herpes simplex virus 1 (EC50s = 3.1 and 4.3, 0.56, and 17.9 μg/ml, respectively). It has antidiabetic effects such that it dose-dependently increases insulin receptor phosphorylation and activation and inhibits hydrolysis of p-nitrophenyl phosphate (p-NPP) catalyzed by protein tyrosine phosphatase 1B (PTP1B; IC50 = 7.3 μM). Amentoflavone reduces the time mice spend immobile in the forced swim test, a measure of antidepressant efficacy, in a dose-dependent manner.
Biochem/physiol Actions
Biflavonoid with anti-inflammatory, anti-viral and cancer chemopreventive activity. It inhibits vascularization of tumors by blocking the activity of angiogenic VEGFs. Blocks the induction of COX-2 and up-regulates PPAR-γ. It is a negative modulator of the GABAA receptor at the benzodiazepine binding site.
Biological Functions
Amentoflavone is a biflavonoid originally isolated from Selaginella. It has a wide variety of biological effects including antibacterial, antioxidant, antiviral, antidiabetic, and neuroprotective activities. Amentoflavone has antiviral activity against the influenza A subtypes H1N1 and H3N2, influenza B, and herpes simplex virus 1 (EC50s = 3.1 and 4.3, 0.56, and 17.9 μg/ml, respectively). It has antidiabetic effects such that it dose-dependently increases insulin receptor phosphorylation and activation and inhibits hydrolysis of p-nitrophenyl phosphate (p-NPP) catalyzed by protein tyrosine phosphatase 1B (PTP1B; IC50 = 7.3 μM). Amentoflavone reduces the time mice spend immobile in the forced swim test, a measure of antidepressant efficacy, in a dose-dependent manner.
Synthesis of Amentoflavone
Amentoflavone, a biflavanoid, is ubiquitously found in plants such as Calophyllum inophyllum, Eucommia ulmoides, Selaginella doederleinii, Paulownia tomentosa var. tomentosa, Ginkgo biloba, Juglans sigillata, Hypericum perforatum. A wide variety of bioactivities such as anti-viral, anti-inflammatory, anti-tumor, antidepressant, anti-oxidant, anti-microbial, analgesic, antiplasmodial, leishmanicidal, lowering blood lipid and hepatoprotective activities have been reported for amentoflavone and its derivatives. Due to the limited natural abundance, the massive production of amentoflavone is not possible from natural resources. Therefore, total synthesis of amentoflavone would be significant as it will be able to solve the availability issue of amentoflavone. Although the synthesis of amentoflavone through Suzuki-reaction was reported two decades ago, which was to link the flavonyl-8-boronic acid with the 3'-iodoflavone to produce amentoflavone, no synthetic effort has been made ever since to explore an alternative scheme such that the flavonyl3'-boronic acid ester can be linked to the 8-iodoflavone through Suzuki coupling. It would be highly beneficial to the scientific community if this alternative scheme is successful, as this will provide a similar but different route for the synthesis of amentoflavone and other similar biflavonoids, because the preparation of flavonylboronic acid, the key intermediate for the synthesis of biflavonoids, from the corresponding halogenated flavone is sometimes problematic due to steric hindrance or unfavorable electronic effects from neighboring substituting groups in the aromatic ring. Therefore, the goal of this work is to provide an alternative synthetic scheme for the production of amentoflavone and other similar biflavonoids utilizing the coupling of flavonyl-3'-boronic acid ester and 8-iodoflavone, instead of the reported method which was based on the coupling of two different intermediates, the flavonyl-8- boronic acid and the 3'-iodoflavone [10]. Here we describe an efficient synthetic pathway to generate amentoflavone.
https://www.hilarispublisher.com/open-access/total-synthesis-of-amentoflavone-2161-0444-1000302.pdf
References
Amentoflavone (C30H18O10) is a common biflavonoid chemically named as 8-[5-(5,7-dihydroxy-4-oxo-4H-chromen-2-yl)-2-hydroxyphenyl]-5,7-dihydroxy-2-(4-hydroxyphenyl)-4H-chromen-4-one, which naturally occurs in many plants. It is also considered as an apigenin dimer linked by a C3′-C8′′ covalent bond. This compound was firstly isolated by Okigawa and his colleagues in 1971 from three plants of the Selaginella species (Selaginella tamariscina (Beauv.) Spring, Selaginella nipponica, and Selaginella pachystachys) .
https://www.mdpi.com/1420-3049/22/2/299/htm
Uses
Amentoflavone, is isolated from an Et acetate ext. of the whole plant of Selaginella tamariscina. It has been shown to have antitumor activity, such as mitochondria-mediated apoptotic cell death. Amentoflavone can interact with many medications by being a potent inhibitor of CYP3A4 and CYP2C9, which are enzymes responsible for the metabolism of some drugs in the body.
Check Digit Verification of cas no
The CAS Registry Mumber 1617-53-4 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 1,6,1 and 7 respectively; the second part has 2 digits, 5 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 1617-53:
(6*1)+(5*6)+(4*1)+(3*7)+(2*5)+(1*3)=74
74 % 10 = 4
So 1617-53-4 is a valid CAS Registry Number.
InChI:InChI=1/C30H18O10/c31-15-4-1-13(2-5-15)24-12-23(38)29-21(36)10-20(35)27(30(29)40-24)17-7-14(3-6-18(17)33)25-11-22(37)28-19(34)8-16(32)9-26(28)39-25/h1-12,31-36H
1617-53-4Relevant articles and documents
-
Ahmad,I.,Ishratullah,K.
, p. 1169 (1981)
-
Isolation of tyrosinase and melanogenesis inhibitory flavonoids from Juniperus chinensis fruits
Park, Sang-a,Jegal, Jonghwan,Chung, Ki Wung,Jung, Hee Jin,Noh, Sang Gyun,Chung, Hae Young,Ahn, Jongmin,Kim, Jinwoong,Yang, Min Hye
, p. 2041 - 2048 (2018)
A new biflavonoid, amentoflavone-7-O-β-D-glucoside, and thirteen known flavonoids were isolated from the fruits of Juniperus chinensis using a bioactivity-guided method and their tyrosinase inhibitory effects were tested using a mushroom tyrosinase bioassay. Two isolates, hypolaetin-7-O-β-D-glucoside and quercetin-7-O-α-L-rhamnoside, were found to reduce tyrosinase activity at a concentration of 50 μM. Quercetin-7-O-α-L-rhamnoside attenuated cellular tyrosinase activity and melanogenesis in α-MSH plus IBMX-stimulated B16F10 melanoma cells. Molecular docking simulation revealed that quercetin-7-O-α-L-rhamnoside inhibits tyrosinase activity by hydrogen bonding with residues His85, His244, Thr261, and Gly281 of tyrosinase.
Biflavanoids and derivatives thereof as antiviral agents
-
, (2008/06/13)
Substantially purified antiviral biflavanoids robustaflavone, hinokiflavone, amentoflavone, agathisflavone, volkensiflavone, morelloflavone, rhusflavanone, succedaneaflavanone, GB-1a, and GB-2a are provided. Antiviral biflavanoid derivatives and salt forms thereof, e.g., robustaflavone tetrasulfate potassium salt, and methods for preparing the same are also disclosed. Pharmaceutical compositions which include the antiviral biflavanoids, derivatives or salts thereof are also provided alone or in combination with at least one antiviral agent such as 3TC. Also disclosed is an improved method for obtaining substantially pure robustaflavone from plant material. The biflavanoid compounds, derivatives or salts thereof of the invention may be used in a method for treating and/or preventing viral infections caused by viral agents such as influenza, e.g., influenza A and B; hepatitis, e.g., hepatitis B; human immunodeficiency virus, e.g., HIV-1; Herpes viruses (HSV-1 and HSV-2); Varicella Zoster virus (VZV); and measles. For instance, semi-synthetic hexa-O-acetate and hexa-O-methyl ether derivatives of robustaflavone have been found to be effective in a method for treating or preventing hepatitis B viral infections. Compositions which include these robustaflavone derivatives along with methods for preparing and using the same are also provided. These compositions may be used alone or in combination with at least one antiviral agent such as 3TC.
